(Q45027981)

8 December 2017

Primary pulmonary hypertension: improved long-term effects and survival with continuous intravenous epoprostenol infusion (English)

1 reference

primary pulmonary hypertension

8 December 2017

arterial hypertension

0 references

1 reference

9

Brundage BH

1 reference

8 December 2017

Shapiro SM

1

1 reference

8 December 2017

Oudiz RJ

2

1 reference

8 December 2017

Cao T

3

1 reference

8 December 2017

Romano MA

4

1 reference

8 December 2017

Beckmann XJ

5

1 reference

8 December 2017

Georgiou D

6

1 reference

8 December 2017

Mandayam S

7

1 reference

8 December 2017

Ginzton LE

8

1 reference

8 December 2017

language of work or name

English

0 references

publication date

1 August 1997

1 reference

Journal of the American College of Cardiology

8 December 2017

1 reference

8 December 2017

30

1 reference

8 December 2017

2

1 reference

8 December 2017

343-349

1 reference

Primary pulmonary hypertension. Length of survival in patients referred for heart-lung transplantation

8 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900187-3

7 January 2021

Survival in patients with primary pulmonary hypertension. Results from a national prospective registry.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900187-3

7 January 2021

The acute administration of vasodilators in primary pulmonary hypertension. Experience from the National Institutes of Health Registry on Primary Pulmonary Hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900187-3

7 January 2021

High-dose calcium channel-blocking therapy for primary pulmonary hypertension: evidence for long-term reduction in pulmonary arterial pressure and regression of right ventricular hypertrophy.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900187-3

7 January 2021

Treatment of primary pulmonary hypertension with continuous intravenous prostacyclin (epoprostenol). Results of a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900187-3

7 January 2021

Survival in primary pulmonary hypertension with long-term continuous intravenous prostacyclin

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900187-3

7 January 2021

A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900187-3

7 January 2021

Noninvasive estimation of right ventricular systolic pressure by Doppler ultrasound in patients with tricuspid regurgitation.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900187-3

7 January 2021

Clinical significance of the pulmonary vasodilator response during short-term infusion of prostacyclin in primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900187-3

7 January 2021

The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2897%2900187-3

7 January 2021

10.1016/S0735-1097(97)00187-3

Identifiers

DOI

1 reference

8 December 2017

1 reference